Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.54 USD | +1.24% | +3.96% | +4.13% |
06/05 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
02/05 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.13% | 12.55B | |
+19.02% | 47.02B | |
+48.77% | 41.86B | |
+0.22% | 41.76B | |
-4.27% | 28.8B | |
+11.58% | 26.05B | |
-22.03% | 19.15B | |
+29.25% | 12.34B | |
-4.65% | 11.82B | |
+20.68% | 11.8B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09